30% Increase in Intel's OPS According to StockDiagnostics.com


NEW YORK, June 4, 2002 (PRIMEZONE) -- StockDiagnostics.com announces that Intel Corporation's OPS (Operational-cashflow per share) increased for its first-quarter, six-months and twelve-months ended March 31, 2002. OPS increased 30% for the three-months, 6% for the six-months and 5% for 12-months ended March 31, 2002 over the comparable periods ended March 31, 2001.

To view four-quarter, twenty-quarter and five-year OPS charts on Intel (Nasdaq:INTC) and over 7,500 public companies, go to: http://www.stockdiagnostics.com

For the first-quarter ended March 31, 2002, Intel's computed OPS was $0.23, an increase of 30% over its OPS of $0.18 for its first-quarter ended March 31, 2001.

For the six-months ended March 31, 2002, Intel's OPS increased to $0.72 an increase of 6% as compared to its OPS of $0.68 for the six-months ended March 31, 2001.

For Intel's trailing 12-months ended March 31, 2002, its OPS increased 5% to OPS of $1.34 as compared to its OPS of $1.28 per share for the comparable trailing 12-months ended March 31, 2001.

What is OPS?

OPS(TM) stands for "Operational-cashflow Per Share." It is derived from the line item "Cash Flow from Operations" which appears in a company's quarterly and annual Cash Flow Statements filed with the Securities & Exchange Commission. "OPS" is calculated by dividing a company's Cash Flow from Operations by the total number of shares outstanding. After conducting in-depth research on Operational-cashflow Per Share, StockDiagnostics.com determined that OPS could be used to measure the quality of a company's EPS and for monitoring its overall financial health. Cash Flow from Operations is a company's financial lifeblood and a sudden decrease in it can drain this lifeblood, causing an increase in debt, share dilution, share price erosion, and in the more extreme cases, bankruptcy.

For more information on OPS go to: http://www.stockdiagnostics.com/member/ops.htm

About StockDiagnostics.com

StockDiagnostics.com has designed and built a proprietary data refinery that automates the process of collecting, sorting, and organizing large amounts of securities pricing and financial data into comparative financial ratios. These ratios are used to identify Financial Statement and securities pricing variances or anomalies and to monitor changes in the performance of public companies.

For more information on StockDiagnostics.com go to: http://www.stockdiagnostics.com/member/help.htm#a1

OPS, OPS Ratings, and The EPS Syndrome are all Trademarks (TM) of StockDiagnostics.com.



            

Kontaktdaten